Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 06, 2014 09:26 ET | Source: Onconova Therapeutics

Onconova Announces Ten Presentations at the 2014 ASH Annual Meeting

--Phase 3 ONTIME Trial Data Selected for Oral Presentation-- --Data from Phase 1/2 Trial of Oral Rigosertib and Azacitidine Combination Highlighted-- NEWTOWN, Pa., Nov. 6, 2014 (GLOBE...
September 03, 2014 07:01 ET | Source: Onconova Therapeutics

Onconova Therapeutics, Inc. to Present at Rodman & Renshaw 16th Annual Global Investment Conference

NEWTOWN, Pa., Sept. 3, 2014 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (Nasdaq:ONTX) a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat...
August 13, 2014 16:01 ET | Source: Onconova Therapeutics

Onconova Therapeutics, Inc. Reports Second Quarter 2014 Financial and Operational Results

NEWTOWN, Pa., Aug. 13, 2014 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (Nasdaq:ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat...
August 06, 2014 08:57 ET | Source: Onconova Therapeutics

Onconova Therapeutics, Inc. Announces Timing for Second Quarter 2014 Financial Results and Conference Call

NEWTOWN, Pa., Aug. 6, 2014 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (Nasdaq:ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat...
May 12, 2014 16:01 ET | Source: Onconova Therapeutics

Onconova Therapeutics, Inc. Reports First Quarter 2014 Financial and Operational Results

NEWTOWN, Pa., May 12, 2014 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (Nasdaq:ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat...
May 06, 2014 08:58 ET | Source: Onconova Therapeutics

Onconova Therapeutics, Inc. Announces Timing for First Quarter 2014 Financial Results and Conference Call

NEWTOWN, Pa., May 6, 2014 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (Nasdaq:ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat...
April 07, 2014 09:33 ET | Source: Onconova Therapeutics

Onconova Development Programs Highlighted in Seven Presentations at AACR Annual Meeting

NEWTOWN, Pa., April 7, 2014 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (Nasdaq:ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat...
March 10, 2014 16:01 ET | Source: Onconova Therapeutics

Onconova Therapeutics, Inc. Reports Fourth Quarter and Year-End 2013 Financial Results and Outlines Key Objectives for 2014

NEWTOWN, Pa., March 10, 2014 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (Nasdaq:ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat...
March 04, 2014 17:45 ET | Source: Onconova Therapeutics

Onconova Therapeutics, Inc. Announces Timing for Fourth Quarter and Year-End 2013 Financial Results and Conference Call

NEWTOWN, Pa., March 4, 2014 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (Nasdaq:ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat...
February 26, 2014 09:02 ET | Source: Onconova Therapeutics

Onconova Therapeutics, Inc. to Present at the Cowen and Company 34th Annual Health Care Conference

NEWTOWN, Pa., Feb. 26, 2014 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (Nasdaq:ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat...